Bombardier to transport C Series Jets to Delta Airlines this year

The reputed Canada based aerospace firm, Bombardier Inc., has apparently won a trade dispute against Boeing in the U.S., encouraging Delta Airlines to take on the delivery of C-series jets from Bombardier. According to Daily Mail, the International Trade Commission (ITC) based in the U.S. has announced that Delta Airlines’ decision to import Bombardier’s 100-150 seat C Series passenger jets did not negatively impact the U.S. industry. Some of the key officials of Delta Airlines have also claimed that it is going to accept the first consignment of 75 CA 100 airplanes it had ordered at the end of 2017.

The CEO of Bombardier Inc. has declared that the company would ship the jets to Delta Airlines in the U.S. after assembling them in Quebec, Canada. He further stated that the delivery of the jets will be only possible till a U.S. assembly line, costing nearly in the range of USD 250 to USD 300 million, will be set up in Alabama. Authentic sources also cite that the ITC, in support of its recent ruling against Boeing, had made a statement that nothing can possibly stop the Canadian based airliner from delivering jets assembled in Quebec to the U.S. airlines. Apparently, the ruling seems to have reversed the initial anti-dumping & countervailing duties tallying 292.21%.

One of the key officials of Bombardier has asserted that 2018 is likely to be a pivotal year for the firm as it will launch its Global 7000 jet business this year. In addition, it may also finalize its C series alliance with Airbus SE. The company may reach a free cash flow break in 2018, which is one of the vital goals of its five-year turnaround strategy.

For the record, Bombardier’s quarterly revenue reached USD 4.72 billion, up from USD 4.38 billion, though a little less than its targeted revenue of USD 4.75 billion.

About Author

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

More News By Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab c...

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purch...

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne mus...